Methyl 3-(2-chloroacetamido)-2-hydroxypropanoate, 98%, 500mg

O-Butylhydroxylamine Hydrochloride>98.0%(N)(T)5g

2-CYCLOPROPYL-2,2-DIFLUOROACETIC ACID, 100mg

(R)-3-Amino-4-(4-bromophenyl)butanoic acid hydrochloride, 95.0%, 100mg

3-Amino-1-ethylpiperidin-2-one, 98%, 250mg

3-methyl-4-oxo-3,4-dihydro-7-quinazolinecarboxylic acid, 95.0%, 100mg

1-(2-Bromophenyl)ethylamine, 95.0%, 25g

3-(3-(2-chloro-6-fluorophenyl)-1,2,4-oxadiazol-5-yl)propan-1-amine hydrochloride, 95.0%, 250mg

Methyl 2-(1,3-dioxo-1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazin-4-yl)acetate, 97%, 500mg

4-Methoxy-2-vinylpyridine, 95.0%, 250mg

GC capillary column ROTI®Cap-FFAP, 50 m, 0.25 mm, 0.25 µm, 1 Piece(s)

TERT-BUTYL 4-(2-CYANOETHYL)PIPERIDINE-1-CARBOXYLATE, 95.0%, 250mg

3-PHENYL-5-(3,4,5-TRIMETHOXYPHENYL)-4,5-DIHYDRO-1H-PYRAZOLE-1-CARBOTHIOAMIDE, 95%, 250mg